These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

524 related articles for article (PubMed ID: 33995989)

  • 1. Treatment with eltrombopag of severe immune thrombocytopenia and hemolytic anemia associated with COVID-19 pneumonia: a case report.
    Gruden G; Beggiato E; Camerino E; Capriotti S; Canepa S; Scandella M; Avolio M; Pittalunga F; Barutta F; Durazzo M
    Ther Adv Hematol; 2021; 12():20406207211011353. PubMed ID: 33995989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Implication of the Effect of the Production of Neutralizing Antibodies Against SARS-Cov-2 for Chronic Immune Thrombocytopenia Flare-Up Associated with COVID-19 Infection: A Case Report and the Review of Literature.
    Maekura C; Muramatsu A; Nagata H; Okamoto H; Onishi A; Kato D; Isa R; Fujino T; Tsukamoto T; Mizutani S; Shimura Y; Kobayashi T; Okumura K; Inaba T; Nukui Y; Kuroda J
    Infect Drug Resist; 2022; 15():2723-2728. PubMed ID: 35668857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First Report of Severe Autoimmune Hemolytic Anemia During Eltrombopag Therapy in Waldenström Macroglobulinemia-Associated Thrombocytopenia.
    Shen Y; Yu F; Ge H; Shao K; Zhou Y; Ye B; Shen Y; Wu D
    Onco Targets Ther; 2021; 14():5027-5033. PubMed ID: 34675547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mixed Warm and Cold Autoimmune Hemolytic Anemia With Concomitant Immune Thrombocytopenia Following Recent SARS-CoV-2 Infection and Ongoing Rhinovirus Infection.
    Karim F; Amardeep K; Yee A; Berson B; Cook P
    Cureus; 2023 May; 15(5):e38509. PubMed ID: 37288234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful eltrombopag treatment of severe refractory thrombocytopenia in chronic myelomonocytic leukemia: Two cases reports: A CARE-compliant article.
    Gao Y; Gong M; Zhang C; Kong X; Ma Y
    Medicine (Baltimore); 2017 Oct; 96(43):e8337. PubMed ID: 29069007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of romiplostim in a hemodialysis patient with primary immune thrombocytopenia.
    Al-Jafar H; Giagounidis A; El-Rashaid K; Al-Ali M; Hakim AA
    Ann Pharmacother; 2012 Nov; 46(11):e31. PubMed ID: 23115229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eltrombopag modulates the phenotypic evolution and potential immunomodulatory roles of monocytes/macrophages in immune thrombocytopenia.
    Yang F; Zong H; Li F; Luo S; Zhang X; Xu Y; Zhang X
    Platelets; 2023 Dec; 34(1):2135694. PubMed ID: 36281771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From chronic immune thrombocytopenia to severe aplastic anemia: recent insights into the evolution of eltrombopag.
    Gill H; Wong RSM; Kwong YL
    Ther Adv Hematol; 2017 May; 8(5):159-174. PubMed ID: 28473904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Cost-effectiveness of Eltrombopag for the Treatment of Immune Thrombocytopenia in the United States.
    Tremblay G; Dolph M; Roy AN; Said Q; Forsythe A
    Clin Ther; 2020 May; 42(5):860-872.e8. PubMed ID: 32199608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recommendations on the Management of Patients with Immune Thrombocytopenia (ITP) in the Context of SARS-CoV-2 Infection and Vaccination: Consensus Guidelines from a Spanish ITP Expert Group.
    González-López TJ; Bárez A; Bernardo-Gutiérrez A; Bernat S; Canaro-Hirnyk M; Entrena-Ureña L; Fernández-Fuertes F; Guinea de Castro JM; Jiménez-Bárcenas R; Pascual-Izquierdo C; Sánchez-González B; Jarque I
    Infect Dis Ther; 2023 Feb; 12(2):303-315. PubMed ID: 36520323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dental procedures in 24 patients with chronic immune thrombocytopenia in prospective clinical studies of eltrombopag.
    Tarantino MD; Fogarty PF; Shah P; Brainsky A
    Platelets; 2015; 26(1):93-6. PubMed ID: 24433306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes and management of immune thrombocytopenia secondary to COVID-19: Cleveland clinic experience.
    Kewan T; Gunaratne TN; Mushtaq K; Alayan D; Daw H; Haddad A
    Transfusion; 2021 Jul; 61(7):2014-2018. PubMed ID: 33724474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eltrombopag: an update on the novel, non-peptide thrombopoietin receptor agonist for the treatment of immune thrombocytopenia.
    Kühne T; Imbach P
    Ann Hematol; 2010 Jul; 89 Suppl 1():67-74. PubMed ID: 20405290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemostatic challenges in patients with chronic immune thrombocytopenia treated with eltrombopag.
    Tarantino MD; Bakshi KK; Brainsky A
    Platelets; 2014; 25(1):55-61. PubMed ID: 23402314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A low birth weight infant with no malformations delivered by a primary immune thrombocytopenia patient treated with eltrombopag.
    Suzuki N; Hiraga J; Hariyama Y; Takagi Y; Ohashi H; Kishigami Y; Oguchi H; Kagami Y
    Int J Hematol; 2018 Jul; 108(1):109-111. PubMed ID: 29188582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eltrombopag, a thrombopoietin- receptor agonist in the treatment of adult chronic immune thrombocytopenia: a review of the efficacy and safety profile.
    Cheng G
    Ther Adv Hematol; 2012 Jun; 3(3):155-64. PubMed ID: 23556122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eltrombopag for treatment of thrombocytopenia-associated disorders.
    Merli P; Strocchio L; Vinti L; Palumbo G; Locatelli F
    Expert Opin Pharmacother; 2015; 16(14):2243-56. PubMed ID: 26364898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 induced immune thrombocytopenic purpura: case report.
    Ashraf S; Alsharedi M
    Stem Cell Investig; 2021; 8():14. PubMed ID: 34386543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adults with immune thrombocytopenia who switched to avatrombopag following prior treatment with eltrombopag or romiplostim: A multicentre US study.
    Al-Samkari H; Jiang D; Gernsheimer T; Liebman H; Lee S; Wojdyla M; Vredenburg M; Cuker A
    Br J Haematol; 2022 May; 197(3):359-366. PubMed ID: 35179784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic immune thrombocytopenia in a child responding only to thrombopoietin receptor agonist.
    Osman ME
    Sudan J Paediatr; 2012; 12(2):60-4. PubMed ID: 27493347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.